Literature DB >> 11232182

Ascites.

T B Reynolds1.   

Abstract

This article reviews the progress made during the last century in understanding and managing ascites. The list of known causes of ascites has lengthened considerably. There is improved understanding of the mechanism of ascites formation and the pathophysiology of the renal sodium retention that accompanies portal hypertensive ascites. Management of ascites has become substantially easier with the advent of new diuretics, and new procedures such as peritoneovenous shunting, transjugular intrahepatic portosystemic stent placement, and liver transplantation.

Entities:  

Mesh:

Year:  2000        PMID: 11232182     DOI: 10.1016/s1089-3261(05)70101-x

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  11 in total

1.  Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.

Authors:  Hong Zhang; Feng Li; Qun Wei; Yu-Fei Zhu
Journal:  Med Oncol       Date:  2010-11-02       Impact factor: 3.064

2.  Use of (18)F-FDG PET/CT to locate primary malignancies in patients with hepatic cirrhosis and malignant ascites.

Authors:  He-Bin Fan; Ai-Jun Wang; Dong-Liang Yang; Jun Xiao; Yun Ai; Lu Huang; Yong Guo; Mu-Xiu Zhou; Juan-Juan Wu; Zhi Li; Fu-Ming Yan; Yi-Ming Wang
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

3.  Ovarian carcinoma in two patients with chronic liver disease.

Authors:  Mehlika Isildak; Gulay-Sain Guven; Murat Kekilli; Yavuz Beyazit; Mustafa Erman
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

Review 4.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

Review 5.  Evaluation and management of patients with refractory ascites.

Authors:  Bahaa Eldeen Senousy; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 6.  KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-07-09

7.  Revision and update on clinical practice guideline for liver cirrhosis.

Authors:  Ki Tae Suk; Soon Koo Baik; Jung Hwan Yoon; Jae Youn Cheong; Yong Han Paik; Chang Hyeong Lee; Young Seok Kim; Jin Woo Lee; Dong Joon Kim; Sung Won Cho; Seong Gyu Hwang; Joo Hyun Sohn; Moon Young Kim; Young Bae Kim; Jae Geun Kim; Yong Kyun Cho; Moon Seok Choi; Hyung Joon Kim; Hyun Woong Lee; Seung Up Kim; Ja Kyung Kim; Jin Young Choi; Dae Won Jun; Won Young Tak; Byung Seok Lee; Byoung Kuk Jang; Woo Jin Chung; Hong Soo Kim; Jae Young Jang; Soung Won Jeong; Sang Gyune Kim; Oh Sang Kwon; Young Kul Jung; Won Hyeok Choe; June Sung Lee; In Hee Kim; Jae Jun Shim; Gab Jin Cheon; Si Hyun Bae; Yeon Seok Seo; Dae Hee Choi; Se Jin Jang
Journal:  Korean J Hepatol       Date:  2012-03-22

Review 8.  Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites.

Authors:  Lin-Lin Huang; Harry Hua-Xiang Xia; Sen-Lin Zhu
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

9.  The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX (©) Catheter.

Authors:  Jason Reinglas; Kayvan Amjadi; Bill Petrcich; Franco Momoli; Thomas Shaw-Stiffel
Journal:  Can J Gastroenterol Hepatol       Date:  2016-06-05

Review 10.  Current management of refractory ascites in patients with cirrhosis.

Authors:  Ruihong Zhao; Juan Lu; Yu Shi; Hong Zhao; Kaijin Xu; Jifang Sheng
Journal:  J Int Med Res       Date:  2017-12-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.